Global Facial Aesthetics
Global Facial Aesthetics

Facial Aesthetics Comprehensive Study by Type (Dermal Fillers, Botulinum Toxin, Chemical Peel, Microdermabrasion), Application (Facial Line Correction Treatment, Scar Treatment, Lip Treatments, Restoration of Volume/ Fullness, Others), Product Type (Dermal Fillers, Botulinum Toxin, Chemical Peel, Microdermabrasion), End-Use (Men, Women) Players and Region - Global Market Outlook to 2026

Facial Aesthetics Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 226 Pages 175 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Facial Aesthetics Market Scope
Facial aesthetics are non-surgical treatments that help in revitalizing the skin. Facial aesthetics are brisk and simple and far less expensive which is done through some devices or aesthetic implants. It’s a decent initial step for women as well as men to accept and implement a wider range of medical aesthetic services. It has additionally pulled in a huge following from patients who might never have thought about healing surgery yet are very satisfied with snappy and short-term care. Dermal fillers and botulinum toxin are used to restore the skin’s naturally youthful appearance. Non-surgical cosmetic interventions can be performed by anyone, and anyone can set up training courses. There are no guidelines regarding what constitutes adequate training or verification of courses at present.

The Facial Aesthetics market study is segmented by Type (Dermal Fillers, Botulinum Toxin, Chemical Peel and Microdermabrasion), by Application (Facial Line Correction Treatment, Scar Treatment, Lip Treatments, Restoration of Volume/ Fullness and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Facial Aesthetics market throughout the predicted period.

Allergan (Ireland), Solta Medical International Inc. (United States), Syneron Medical (United States), Photomedex, Inc. (United States), Cynosure (United States), Lumenis Ltd. (Israel), Johnson & Johnson (United States), Zeltiq Aesthetics (United States), Merz Pharmaceuticals GmbH (Germany), Galderma (Switzerland), Alma Lasers Ltd. (Israel), Bausch Health Companies Inc. (Canada), Merz Pharmaceuticals GmbH (Germany), Novartis AG (Switzerland) and Nestlé Skin Health (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Anika Therapeutics Inc. (United States), Teoxane SA (Switzerland), Alpha Aesthetics (United States) and Galderma Laboratories, L.P. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Facial Aesthetics market by Type, Application and Region.

On the basis of geography, the market of Facial Aesthetics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In January 2020, Allergan announced the launch of the SkinMedica Instant Bright Eye Cream for enhancing the skin around eyes, On January 10th 2020 - Revance Therapeutics, a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, signed a U.S. distribution agreement with TEOXANE SA , making Revance the exclusive commercialization partner of the Swiss company’s modern and innovative Resilient Hyaluronic Acid (RHA) technology. and In April 2019, Merz Pharma launched a new dermal filler called the Belotero Revive dermal filler, a combination of hyaluronic acid and glycerol
Currently, there is no regulatory body or any formal process of regulation regarding the administration of non-surgical facial aesthetics. Regardless of the societal expectation that such an industry would have strict regulations and guidelines, currently, only procedures requiring surgery (i.e. those involving a surgical incision) are required to be carried out by a qualified medical professional. Botulinum toxin injections, dermal fillers, and other ‘minimally invasive’ cosmetic treatments can be administered by anyone, regardless of their qualifications.

Market Trend
  • Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures
  • Increasing Demand for Aesthetic Treatments among Men

Market Drivers
  • Increasing Number of Clinics and Medical Spas
  • High Availability of Financial and Infrastructural Resources with Hospitals

Opportunities
  • The Availability of Technologically Advanced & User-Friendly Products
  • Technologically Advanced Devices

Restraints
  • High Cost of Treatment
  • Risk of Malfunctions Associated Mostly With Implants

Challenges
  • Low Reimbursements


Key Target Audience
Service Providers of Facial Aesthetics, End-Users, Manufacturers of Aesthetics Devices and Cosmetic, Healthcare Industry, Governmental Bodies, Regulatory Bodies and Others

Frequently asked questions:
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Facial Aesthetics Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Type
  • Dermal Fillers
  • Botulinum Toxin
  • Chemical Peel
  • Microdermabrasion
By Application
  • Facial Line Correction Treatment
  • Scar Treatment
  • Lip Treatments
  • Restoration of Volume/ Fullness
  • Others
By Product Type
  • Dermal Fillers
  • Botulinum Toxin
  • Chemical Peel
  • Microdermabrasion

By End-Use
  • Men
  • Women

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Clinics and Medical Spas
      • 3.2.2. High Availability of Financial and Infrastructural Resources with Hospitals
    • 3.3. Market Challenges
      • 3.3.1. Low Reimbursements
    • 3.4. Market Trends
      • 3.4.1. Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures
      • 3.4.2. Increasing Demand for Aesthetic Treatments among Men
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Facial Aesthetics, by Type, Application, Product Type, End-Use and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Facial Aesthetics (Value)
      • 5.2.1. Global Facial Aesthetics by: Type (Value)
        • 5.2.1.1. Dermal Fillers
        • 5.2.1.2. Botulinum Toxin
        • 5.2.1.3. Chemical Peel
        • 5.2.1.4. Microdermabrasion
      • 5.2.2. Global Facial Aesthetics by: Application (Value)
        • 5.2.2.1. Facial Line Correction Treatment
        • 5.2.2.2. Scar Treatment
        • 5.2.2.3. Lip Treatments
        • 5.2.2.4. Restoration of Volume/ Fullness
        • 5.2.2.5. Others
      • 5.2.3. Global Facial Aesthetics by: Type (Value)
        • 5.2.3.1. Dermal Fillers
        • 5.2.3.2. Botulinum Toxin
        • 5.2.3.3. Chemical Peel
        • 5.2.3.4. Microdermabrasion
      • 5.2.4. Global Facial Aesthetics by: Product Type (Value)
        • 5.2.4.1. Dermal Fillers
        • 5.2.4.2. Botulinum Toxin
        • 5.2.4.3. Chemical Peel
        • 5.2.4.4. Microdermabrasion
      • 5.2.5. Global Facial Aesthetics by: End-Use (Value)
        • 5.2.5.1. Men
        • 5.2.5.2. Women
      • 5.2.6. Global Facial Aesthetics Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Facial Aesthetics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Solta Medical International Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Syneron Medical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Photomedex, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cynosure (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lumenis Ltd. (Israel)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Johnson & Johnson (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Zeltiq Aesthetics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merz Pharmaceuticals GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Galderma (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Alma Lasers Ltd. (Israel)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Bausch Health Companies Inc. (Canada)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Merz Pharmaceuticals GmbH (Germany)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Novartis AG (Switzerland)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Nestlé Skin Health (Switzerland)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Facial Aesthetics Sale, by Type, Application, Product Type, End-Use and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Facial Aesthetics (Value)
      • 7.2.1. Global Facial Aesthetics by: Type (Value)
        • 7.2.1.1. Dermal Fillers
        • 7.2.1.2. Botulinum Toxin
        • 7.2.1.3. Chemical Peel
        • 7.2.1.4. Microdermabrasion
      • 7.2.2. Global Facial Aesthetics by: Application (Value)
        • 7.2.2.1. Facial Line Correction Treatment
        • 7.2.2.2. Scar Treatment
        • 7.2.2.3. Lip Treatments
        • 7.2.2.4. Restoration of Volume/ Fullness
        • 7.2.2.5. Others
      • 7.2.3. Global Facial Aesthetics by: Type (Value)
        • 7.2.3.1. Dermal Fillers
        • 7.2.3.2. Botulinum Toxin
        • 7.2.3.3. Chemical Peel
        • 7.2.3.4. Microdermabrasion
      • 7.2.4. Global Facial Aesthetics by: Product Type (Value)
        • 7.2.4.1. Dermal Fillers
        • 7.2.4.2. Botulinum Toxin
        • 7.2.4.3. Chemical Peel
        • 7.2.4.4. Microdermabrasion
      • 7.2.5. Global Facial Aesthetics by: End-Use (Value)
        • 7.2.5.1. Men
        • 7.2.5.2. Women
      • 7.2.6. Global Facial Aesthetics Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Facial Aesthetics: by Type(USD Million)
  • Table 2. Facial Aesthetics Dermal Fillers , by Region USD Million (2015-2020)
  • Table 3. Facial Aesthetics Botulinum Toxin , by Region USD Million (2015-2020)
  • Table 4. Facial Aesthetics Chemical Peel , by Region USD Million (2015-2020)
  • Table 5. Facial Aesthetics Microdermabrasion , by Region USD Million (2015-2020)
  • Table 6. Facial Aesthetics: by Application(USD Million)
  • Table 7. Facial Aesthetics Facial Line Correction Treatment , by Region USD Million (2015-2020)
  • Table 8. Facial Aesthetics Scar Treatment , by Region USD Million (2015-2020)
  • Table 9. Facial Aesthetics Lip Treatments , by Region USD Million (2015-2020)
  • Table 10. Facial Aesthetics Restoration of Volume/ Fullness , by Region USD Million (2015-2020)
  • Table 11. Facial Aesthetics Others , by Region USD Million (2015-2020)
  • Table 12. Facial Aesthetics: by Type(USD Million)
  • Table 13. Facial Aesthetics Dermal Fillers , by Region USD Million (2015-2020)
  • Table 14. Facial Aesthetics Botulinum Toxin , by Region USD Million (2015-2020)
  • Table 15. Facial Aesthetics Chemical Peel , by Region USD Million (2015-2020)
  • Table 16. Facial Aesthetics Microdermabrasion , by Region USD Million (2015-2020)
  • Table 17. Facial Aesthetics: by Product Type(USD Million)
  • Table 18. Facial Aesthetics Dermal Fillers , by Region USD Million (2015-2020)
  • Table 19. Facial Aesthetics Botulinum Toxin , by Region USD Million (2015-2020)
  • Table 20. Facial Aesthetics Chemical Peel , by Region USD Million (2015-2020)
  • Table 21. Facial Aesthetics Microdermabrasion , by Region USD Million (2015-2020)
  • Table 22. Facial Aesthetics: by End-Use(USD Million)
  • Table 23. Facial Aesthetics Men , by Region USD Million (2015-2020)
  • Table 24. Facial Aesthetics Women , by Region USD Million (2015-2020)
  • Table 25. South America Facial Aesthetics, by Country USD Million (2015-2020)
  • Table 26. South America Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 27. South America Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 28. South America Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 29. South America Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 30. Brazil Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 31. Brazil Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 32. Brazil Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 33. Brazil Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 34. Argentina Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 35. Argentina Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 36. Argentina Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 37. Argentina Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 38. Rest of South America Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 39. Rest of South America Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 40. Rest of South America Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 41. Rest of South America Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 42. Asia Pacific Facial Aesthetics, by Country USD Million (2015-2020)
  • Table 43. Asia Pacific Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 44. Asia Pacific Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 45. Asia Pacific Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 46. Asia Pacific Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 47. China Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 48. China Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 49. China Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 50. China Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 51. Japan Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 52. Japan Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 53. Japan Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 54. Japan Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 55. India Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 56. India Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 57. India Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 58. India Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 59. South Korea Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 60. South Korea Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 61. South Korea Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 62. South Korea Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 63. Taiwan Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 64. Taiwan Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 65. Taiwan Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 66. Taiwan Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 67. Australia Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 68. Australia Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 69. Australia Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 70. Australia Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 74. Rest of Asia-Pacific Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 75. Europe Facial Aesthetics, by Country USD Million (2015-2020)
  • Table 76. Europe Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 77. Europe Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 78. Europe Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 79. Europe Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 80. Germany Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 81. Germany Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 82. Germany Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 83. Germany Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 84. France Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 85. France Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 86. France Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 87. France Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 88. Italy Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 89. Italy Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 90. Italy Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 91. Italy Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 92. United Kingdom Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 93. United Kingdom Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 94. United Kingdom Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 95. United Kingdom Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 96. Netherlands Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 97. Netherlands Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 98. Netherlands Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 99. Netherlands Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 100. Rest of Europe Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 101. Rest of Europe Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 102. Rest of Europe Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 103. Rest of Europe Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 104. MEA Facial Aesthetics, by Country USD Million (2015-2020)
  • Table 105. MEA Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 106. MEA Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 107. MEA Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 108. MEA Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 109. Middle East Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 110. Middle East Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 111. Middle East Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 112. Middle East Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 113. Africa Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 114. Africa Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 115. Africa Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 116. Africa Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 117. North America Facial Aesthetics, by Country USD Million (2015-2020)
  • Table 118. North America Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 119. North America Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 120. North America Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 121. North America Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 122. United States Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 123. United States Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 124. United States Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 125. United States Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 126. Canada Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 127. Canada Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 128. Canada Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 129. Canada Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 130. Mexico Facial Aesthetics, by Type USD Million (2015-2020)
  • Table 131. Mexico Facial Aesthetics, by Application USD Million (2015-2020)
  • Table 132. Mexico Facial Aesthetics, by Product Type USD Million (2015-2020)
  • Table 133. Mexico Facial Aesthetics, by End-Use USD Million (2015-2020)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Facial Aesthetics: by Type(USD Million)
  • Table 150. Facial Aesthetics Dermal Fillers , by Region USD Million (2021-2026)
  • Table 151. Facial Aesthetics Botulinum Toxin , by Region USD Million (2021-2026)
  • Table 152. Facial Aesthetics Chemical Peel , by Region USD Million (2021-2026)
  • Table 153. Facial Aesthetics Microdermabrasion , by Region USD Million (2021-2026)
  • Table 154. Facial Aesthetics: by Application(USD Million)
  • Table 155. Facial Aesthetics Facial Line Correction Treatment , by Region USD Million (2021-2026)
  • Table 156. Facial Aesthetics Scar Treatment , by Region USD Million (2021-2026)
  • Table 157. Facial Aesthetics Lip Treatments , by Region USD Million (2021-2026)
  • Table 158. Facial Aesthetics Restoration of Volume/ Fullness , by Region USD Million (2021-2026)
  • Table 159. Facial Aesthetics Others , by Region USD Million (2021-2026)
  • Table 160. Facial Aesthetics: by Type(USD Million)
  • Table 161. Facial Aesthetics Dermal Fillers , by Region USD Million (2021-2026)
  • Table 162. Facial Aesthetics Botulinum Toxin , by Region USD Million (2021-2026)
  • Table 163. Facial Aesthetics Chemical Peel , by Region USD Million (2021-2026)
  • Table 164. Facial Aesthetics Microdermabrasion , by Region USD Million (2021-2026)
  • Table 165. Facial Aesthetics: by Product Type(USD Million)
  • Table 166. Facial Aesthetics Dermal Fillers , by Region USD Million (2021-2026)
  • Table 167. Facial Aesthetics Botulinum Toxin , by Region USD Million (2021-2026)
  • Table 168. Facial Aesthetics Chemical Peel , by Region USD Million (2021-2026)
  • Table 169. Facial Aesthetics Microdermabrasion , by Region USD Million (2021-2026)
  • Table 170. Facial Aesthetics: by End-Use(USD Million)
  • Table 171. Facial Aesthetics Men , by Region USD Million (2021-2026)
  • Table 172. Facial Aesthetics Women , by Region USD Million (2021-2026)
  • Table 173. South America Facial Aesthetics, by Country USD Million (2021-2026)
  • Table 174. South America Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 175. South America Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 176. South America Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 177. South America Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 178. Brazil Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 179. Brazil Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 180. Brazil Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 181. Brazil Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 182. Argentina Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 183. Argentina Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 184. Argentina Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 185. Argentina Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 186. Rest of South America Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 187. Rest of South America Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 188. Rest of South America Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 189. Rest of South America Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 190. Asia Pacific Facial Aesthetics, by Country USD Million (2021-2026)
  • Table 191. Asia Pacific Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 192. Asia Pacific Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 193. Asia Pacific Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 194. Asia Pacific Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 195. China Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 196. China Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 197. China Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 198. China Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 199. Japan Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 200. Japan Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 201. Japan Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 202. Japan Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 203. India Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 204. India Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 205. India Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 206. India Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 207. South Korea Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 208. South Korea Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 209. South Korea Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 210. South Korea Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 211. Taiwan Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 212. Taiwan Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 213. Taiwan Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 214. Taiwan Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 215. Australia Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 216. Australia Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 217. Australia Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 218. Australia Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 219. Rest of Asia-Pacific Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 220. Rest of Asia-Pacific Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 221. Rest of Asia-Pacific Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 222. Rest of Asia-Pacific Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 223. Europe Facial Aesthetics, by Country USD Million (2021-2026)
  • Table 224. Europe Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 225. Europe Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 226. Europe Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 227. Europe Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 228. Germany Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 229. Germany Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 230. Germany Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 231. Germany Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 232. France Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 233. France Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 234. France Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 235. France Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 236. Italy Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 237. Italy Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 238. Italy Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 239. Italy Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 240. United Kingdom Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 241. United Kingdom Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 242. United Kingdom Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 243. United Kingdom Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 244. Netherlands Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 245. Netherlands Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 246. Netherlands Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 247. Netherlands Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 248. Rest of Europe Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 249. Rest of Europe Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 250. Rest of Europe Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 251. Rest of Europe Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 252. MEA Facial Aesthetics, by Country USD Million (2021-2026)
  • Table 253. MEA Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 254. MEA Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 255. MEA Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 256. MEA Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 257. Middle East Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 258. Middle East Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 259. Middle East Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 260. Middle East Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 261. Africa Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 262. Africa Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 263. Africa Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 264. Africa Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 265. North America Facial Aesthetics, by Country USD Million (2021-2026)
  • Table 266. North America Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 267. North America Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 268. North America Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 269. North America Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 270. United States Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 271. United States Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 272. United States Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 273. United States Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 274. Canada Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 275. Canada Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 276. Canada Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 277. Canada Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 278. Mexico Facial Aesthetics, by Type USD Million (2021-2026)
  • Table 279. Mexico Facial Aesthetics, by Application USD Million (2021-2026)
  • Table 280. Mexico Facial Aesthetics, by Product Type USD Million (2021-2026)
  • Table 281. Mexico Facial Aesthetics, by End-Use USD Million (2021-2026)
  • Table 282. Research Programs/Design for This Report
  • Table 283. Key Data Information from Secondary Sources
  • Table 284. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Facial Aesthetics: by Type USD Million (2015-2020)
  • Figure 5. Global Facial Aesthetics: by Application USD Million (2015-2020)
  • Figure 6. Global Facial Aesthetics: by Type USD Million (2015-2020)
  • Figure 7. Global Facial Aesthetics: by Product Type USD Million (2015-2020)
  • Figure 8. Global Facial Aesthetics: by End-Use USD Million (2015-2020)
  • Figure 9. South America Facial Aesthetics Share (%), by Country
  • Figure 10. Asia Pacific Facial Aesthetics Share (%), by Country
  • Figure 11. Europe Facial Aesthetics Share (%), by Country
  • Figure 12. MEA Facial Aesthetics Share (%), by Country
  • Figure 13. North America Facial Aesthetics Share (%), by Country
  • Figure 14. Global Facial Aesthetics share by Players 2020 (%)
  • Figure 15. Global Facial Aesthetics share by Players (Top 3) 2020(%)
  • Figure 16. Global Facial Aesthetics share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Allergan (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Allergan (Ireland) Revenue: by Geography 2020
  • Figure 20. Solta Medical International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Solta Medical International Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Syneron Medical (United States) Revenue, Net Income and Gross profit
  • Figure 23. Syneron Medical (United States) Revenue: by Geography 2020
  • Figure 24. Photomedex, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Photomedex, Inc. (United States) Revenue: by Geography 2020
  • Figure 26. Cynosure (United States) Revenue, Net Income and Gross profit
  • Figure 27. Cynosure (United States) Revenue: by Geography 2020
  • Figure 28. Lumenis Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 29. Lumenis Ltd. (Israel) Revenue: by Geography 2020
  • Figure 30. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 31. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 32. Zeltiq Aesthetics (United States) Revenue, Net Income and Gross profit
  • Figure 33. Zeltiq Aesthetics (United States) Revenue: by Geography 2020
  • Figure 34. Merz Pharmaceuticals GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Merz Pharmaceuticals GmbH (Germany) Revenue: by Geography 2020
  • Figure 36. Galderma (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Galderma (Switzerland) Revenue: by Geography 2020
  • Figure 38. Alma Lasers Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 39. Alma Lasers Ltd. (Israel) Revenue: by Geography 2020
  • Figure 40. Bausch Health Companies Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 41. Bausch Health Companies Inc. (Canada) Revenue: by Geography 2020
  • Figure 42. Merz Pharmaceuticals GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 43. Merz Pharmaceuticals GmbH (Germany) Revenue: by Geography 2020
  • Figure 44. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 45. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 46. Nestlé Skin Health (Switzerland) Revenue, Net Income and Gross profit
  • Figure 47. Nestlé Skin Health (Switzerland) Revenue: by Geography 2020
  • Figure 48. Global Facial Aesthetics: by Type USD Million (2021-2026)
  • Figure 49. Global Facial Aesthetics: by Application USD Million (2021-2026)
  • Figure 50. Global Facial Aesthetics: by Type USD Million (2021-2026)
  • Figure 51. Global Facial Aesthetics: by Product Type USD Million (2021-2026)
  • Figure 52. Global Facial Aesthetics: by End-Use USD Million (2021-2026)
  • Figure 53. South America Facial Aesthetics Share (%), by Country
  • Figure 54. Asia Pacific Facial Aesthetics Share (%), by Country
  • Figure 55. Europe Facial Aesthetics Share (%), by Country
  • Figure 56. MEA Facial Aesthetics Share (%), by Country
  • Figure 57. North America Facial Aesthetics Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Allergan (Ireland)
  • Solta Medical International Inc. (United States)
  • Syneron Medical (United States)
  • Photomedex, Inc. (United States)
  • Cynosure (United States)
  • Lumenis Ltd. (Israel)
  • Johnson & Johnson (United States)
  • Zeltiq Aesthetics (United States)
  • Merz Pharmaceuticals GmbH (Germany)
  • Galderma (Switzerland)
  • Alma Lasers Ltd. (Israel)
  • Bausch Health Companies Inc. (Canada)
  • Merz Pharmaceuticals GmbH (Germany)
  • Novartis AG (Switzerland)
  • Nestlé Skin Health (Switzerland)
Additional players considered in the study are as follows:
Anika Therapeutics Inc. (United States) , Teoxane SA (Switzerland) , Alpha Aesthetics (United States) , Galderma Laboratories, L.P. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation